查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475913

数位呼吸市场：依产品类型、最终用户、地区 - 全球产业分析、规模、占有率、成长、趋势、预测，2024-2032 年

Digital Respiratory Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 300 Pages | 商品交期: 2-5个工作天内

价格
简介目录

本报告详细分析了 2024 年至 2032 年数位呼吸市场的市场动态、成长因素、课题和新兴趋势。提供有关数位呼吸市场的现状和未来前景的见解。

全球数位呼吸市场预计将从2024年的671.9亿美元成长到2032年的4,000亿美元，复合年增长率为25%。

重要见解

  • 预计市场规模（2024年）：671.9亿美元
  • 预计市场规模（2032年）4,000亿美元
  • 全球市场成长率（2024-2032年复合年增长率）：25%

数位呼吸市场 - 报告范围：

数位呼吸包括各种基于技术的解决方案，用于管理和治疗气喘、慢性阻塞性肺病 (COPD) 和睡眠呼吸中止症等呼吸系统疾病。本报告概述了数位呼吸器采用增加的关键驱动因素，包括感测器技术、远距医疗和远端患者监测的进步。

市场驱动因素：

有几个因素正在推动市场成长。首先，包括气喘、慢性阻塞性肺病和阻塞性睡眠呼吸中止症在内的呼吸系统疾病的全球盛行率不断上升，推动了对用于早期检测、监测和管理这些疾病的数位呼吸机的需求。此外，穿戴式感测器、行动应用程式和连接装置等数位健康解决方案的技术进步可以即时监测肺功能、氧饱和度和呼吸频率等呼吸参数，使患者和医疗保健提供者能够获得可操作的见解，以实现个人化治疗治疗策略和及时介入。此外，呼吸系统疾病管理中对预防性护理、患者参与和自我管理的日益重视正在推动数位呼吸器的采用，特别是在服务不足和偏远的医疗保健环境中，用于远端监控、远端会诊和促进虚拟护理提供模式。

市场限制因素：

儘管前景乐观，但数位呼吸市场仍面临一定的课题。资料隐私问题、互通性问题和监管障碍等因素可能会阻碍数位呼吸器的广泛采用和整合到现有的医疗生态系统中，从而限制其实用性和可扩展性。此外，医疗保健取得、数位素养和社会经济地位的差异加剧了呼吸系统疾病管理和病情恶化预防方面的不平等，导致边缘化人群中数位呼吸器的市场渗透率和采用率可能受到阻碍。此外，数位医疗技术的报销限制、医疗报销政策和保险范围限制可能会影响数位呼吸市场动态、投资决策和商业化策略，对市场成长和永续性构成课题。

市场机会：

数位呼吸市场存在巨大的创新和市场拓展机会。製造商和开发人员正在寻求创建用户友好且经济高效的数位呼吸机，并具有无线连接、基于云端的数据分析以及用于预测分析和个人化护理建议的人工智慧演算法等增强功能。例如，具有感测器和蓝牙连接的智慧吸入器可以即时追踪药物依从性、吸入技术和环境触发因素，从而提高呼吸系统疾病患者的治疗依从性、吸入技术和气喘控制。此外，与医疗保健提供者、支付者和技术合作伙伴的策略联盟、合作伙伴关係和试点计画将加速数位呼吸机在临床实践、家庭医疗保健和远距医疗应用中的市场进入、验证和采用。此外，在研发、临床验证和监管合规方面的投资将使公司能够解决未满足的需求、展示临床疗效并获得数位呼吸器的监管批准，使全球的数位呼吸器能够推动市场差异化和竞争优势。

报告中涵盖的关键问题

  • 2024年至2032年数位呼吸市场的预期复合年增长率是多少？
  • 推动数位呼吸市场成长的关键因素是什么？
  • 哪种类型的数位呼吸器占据最大的市场占有率？
  • 谁是全球数位呼吸市场的主要参与者？
  • 主要参与者采取哪些策略来维持数位呼吸市场的竞争力？

目录

第一章执行摘要

第二章市场概况

  • 市场范围/分类
  • 市场定义/范围/限制

第三章市场背景

  • 市场动态
  • 情景预测
  • 机会图分析
  • 投资可行性矩阵
  • PESTLE 与 Porter 分析
  • 监管状况
  • 各地区母公司市场前景

第四章全球数位呼吸市场分析

  • 过去的市场规模分析（2019-2023）
  • 目前和未来的市场规模预测（2024-2032）
    • 同比增长趋势分析
    • 绝对量机会分析

第五章全球数位呼吸市场分析：依产品

  • 简介/主要发现
  • 过去的市场规模分析（2019-2023）：依产品
  • 目前和未来的市场规模分析和预测（2024-2032）：依产品
    • 智慧吸入器和雾化器
    • 传感器和应用程序
  • 年比成长趋势分析（2019-2023）：依产品
  • 绝对价值机会分析（2024-2032）：依产品

第六章全球数位呼吸市场分析：依指标分类

  • 简介/主要发现
  • 过去的市场规模分析（2019-2023）：依指标
  • 目前和未来的市场规模分析和预测（2024-2032）：依指标
    • 哮喘
    • 慢性阻塞性肺疾病
    • 其他疾病
  • 年比成长趋势分析（2019-2023）：依指标分类
  • 绝对机会分析（2024-2032）：依迹象分类

第七章全球数位呼吸市场分析：依最终用途

  • 简介/主要发现
  • 历史市场规模分析（2019-2023）：依最终用途
  • 目前与未来的市场规模分析与预测（2024-2032）：依最终用途
    • 医院
    • 居家护理
    • 其他
  • 年比成长趋势分析（2019-2023）：依最终用途
  • 绝对价值机会分析（2024-2032）：依最终用途

第八章全球数位呼吸市场分析：依分销管道

  • 简介/主要发现
  • 过去的市场规模分析（2019-2023）：依分销管道
  • 目前和未来的市场规模分析和预测（2024-2032）：依分销管道
    • 医院药房
    • 零售药店
    • 网上药店
  • 年比成长趋势分析（2019-2023）：依分销管道
  • 绝对机会分析（2024-2032）：依分销管道

第九章全球数位呼吸市场分析：依地区

  • 介绍
  • 过去的市场规模分析（2019-2023）：依地区
  • 目前和未来的市场规模分析和预测（2024-2032）：依地区
    • 北美
    • 拉丁美洲
    • 欧洲
    • 南亚
    • 东亚
    • 大洋洲
    • 中东/非洲
  • 依地区划分的市场吸引力分析

第10章北美数位呼吸市场分析：依国家/地区

第十一章拉丁美洲数字呼吸市场分析：依国家/地区

第十二章欧洲数位呼吸市场分析：依国家分类

第十三章南亚数字呼吸市场分析：依国家分类

第14章东亚数位呼吸市场分析：依国家分类

第十五章大洋洲数位呼吸市场分析：依国家分类

第十六章中东和非洲数位呼吸市场分析：依国家/地区

第十七章 主要国家数位呼吸市场分析

  • 美国
  • 加拿大
  • 巴西
  • 墨西哥
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 印度
  • 马来西亚
  • 新加坡
  • 泰国
  • 中国
  • 日本
  • 韩国
  • 澳大利亚
  • 纽西兰
  • 海湾合作委员会国家
  • 南非
  • 以色列

第18章市场结构分析

  • 比赛仪表板
  • 竞争标桿
  • 主要参与者的市场占有率分析

第 19 章 竞争分析

  • 衝突的衝突
    • COHERO Health Inc.
    • Cognita Labs
    • Adherium Limited
    • Amiko Digital Health Limited
    • Teva Pharmaceuticals Industries Ltd.
    • Propeller Health
    • Novartis AG
    • Pneuma Respiratory Inc.
    • 3M Health Care Limited
    • AireHealth, Inc.

第 20 章假设与缩写

第21章研究方法论

简介目录
Product Code: PMRREP33183

The Digital Respiratory Devices Market report by Persistence Market Research provides an in-depth analysis of market dynamics, growth factors, challenges, and emerging trends from 2024 to 2032. It offers insights into the current state and future outlook of the Digital Respiratory Devices Market.

The global digital respiratory devices market is projected to grow at a compound annual growth rate (CAGR) of 25% from USD 67.19 billion in 2024 to USD 400 billion by 2032.

Key Insights:

  • Estimated Market Size (2024): USD 67.19 Billion
  • Projected Market Size (2032): USD 400 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 25%

Digital Respiratory Devices Market - Report Scope:

Digital respiratory devices encompass a range of technology-enabled solutions used in the management and treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. The report outlines key drivers behind the increasing adoption of digital respiratory devices, including advancements in sensor technology, telemedicine, and remote patient monitoring.

Market Growth Drivers:

The market's growth is driven by several factors. Firstly, the rising prevalence of respiratory diseases, including asthma, COPD, and obstructive sleep apnea, globally, fuels demand for digital respiratory devices for early detection, monitoring, and management of these conditions. Additionally, technological advancements in digital health solutions, including wearable sensors, mobile apps, and connected devices, enable real-time monitoring of respiratory parameters such as lung function, oxygen saturation, and respiratory rate, empowering patients and healthcare providers with actionable insights for personalized treatment strategies and timely interventions. Moreover, the growing emphasis on preventive care, patient engagement, and self-management in respiratory disease management drives adoption of digital respiratory devices, facilitating remote monitoring, teleconsultations, and virtual care delivery models, particularly in underserved and remote healthcare settings.

Market Restraints:

Despite the positive outlook, the Digital Respiratory Devices Market faces certain challenges. Factors such as data privacy concerns, interoperability issues, and regulatory barriers may impede widespread adoption and integration of digital respiratory devices into existing healthcare ecosystems, limiting their utility and scalability. Moreover, disparities in healthcare access, digital literacy, and socioeconomic status may exacerbate inequalities in respiratory disease management and exacerbation prevention, hindering market penetration and adoption rates of digital respiratory devices among marginalized populations. Additionally, reimbursement limitations, healthcare reimbursement policies, and coverage restrictions for digital health technologies may impact market dynamics, investment decisions, and commercialization strategies for digital respiratory devices, posing challenges to market growth and sustainability.

Market Opportunities:

The Digital Respiratory Devices Market offers significant opportunities for innovation and market expansion. Manufacturers and developers can focus on developing user-friendly, cost-effective digital respiratory devices with enhanced features such as wireless connectivity, cloud-based data analytics, and artificial intelligence algorithms for predictive analytics and personalized care recommendations. For instance, smart inhalers equipped with sensors and Bluetooth connectivity enable real-time tracking of medication adherence, inhaler technique, and environmental triggers, enhancing treatment adherence, inhaler technique, and asthma control in patients with respiratory conditions. Moreover, strategic collaborations, partnerships, and pilot projects with healthcare providers, payers, and technology partners facilitate market access, validation, and adoption of digital respiratory devices in clinical practice, home healthcare, and telemedicine applications. Furthermore, investments in research and development, clinical validation, and regulatory compliance enable companies to address unmet needs, demonstrate clinical efficacy, and gain regulatory approvals for digital respiratory devices, driving market differentiation and competitive advantage in the global digital respiratory devices market.

Key Questions Addressed in the Report:

  • What is the Expected CAGR of the Digital Respiratory Devices Market from 2024 to 2032?
  • What are the Key Factors Driving the Growth of the Digital Respiratory Devices Market?
  • Which Type of Digital Respiratory Device Holds the Largest Market Share?
  • Who are the Key Players in the Global Digital Respiratory Devices Market?
  • What Strategies are Adopted by Leading Companies to Stay Competitive in the Digital Respiratory Devices Market?

Competitive Landscape and Business Strategies:

Key players in the Digital Respiratory Devices Market include Propeller Health (a ResMed Company), Adherium Limited, Teva Pharmaceuticals Industries Ltd., Cohero Health, and NuvoAir, among others. These companies focus on product innovation, strategic partnerships, and market expansion to maintain a competitive edge in the market. For instance, Propeller Health offers a range of digital health solutions for asthma and COPD management, including sensor-enabled inhaler devices, mobile apps, and population health analytics platforms, while Adherium Limited specializes in smart medication adherence solutions for respiratory diseases. Market players also invest in clinical trials, real-world evidence generation, and regulatory approvals to demonstrate clinical efficacy, safety, and value proposition of digital respiratory devices, fostering adoption by healthcare providers, payers, and patients in the global market.

Key Companies Profiled:

  • COHERO Health Inc.
  • Cognita Labs
  • Adherium limited
  • Amiko Digital Health Limited
  • Teva pharmaceuticals industries Ltd.
  • Propeller Health
  • Novartis AG
  • Pneuma Respiratory Inc.
  • 3m Health Care Limited
  • AireHealth, Inc.

Digital Respiratory Devices Market Segmentation:

By Product

  • Smart Inhalers & Nebulizers
  • Sensors & Apps

By Indication

  • Asthma
  • COPD
  • Other Diseases

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End Use

  • Hospitals
  • Homecare Settings
  • Other settings

By Region

  • North America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 5.3.1. Smart inhalers & Nebulizers
    • 5.3.2. Sensors & Apps
  • 5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product, 2024-2032

6. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Indication

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2024-2032
    • 6.3.1. Asthma
    • 6.3.2. COPD
    • 6.3.3. Other Diseases
  • 6.4. Y-o-Y Growth Trend Analysis By Indication, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Indication, 2024-2032

7. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By End-Use

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By End-Use , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-Use , 2024-2032
    • 7.3.1. Hospitals
    • 7.3.2. Homecare Settings
    • 7.3.3. Other settings
  • 7.4. Y-o-Y Growth Trend Analysis By End-Use , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By End-Use , 2024-2032

8. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Distribution Channel

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2032
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024-2032

9. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. South Asia
    • 9.3.5. East Asia
    • 9.3.6. Oceania
    • 9.3.7. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Indication
    • 10.2.4. By End-Use
    • 10.2.5. By Distribution Channel
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Indication
    • 10.3.4. By End-Use
    • 10.3.5. By Distribution Channel
  • 10.4. Key Takeaways

11. Latin America Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Indication
    • 11.2.4. By End-Use
    • 11.2.5. By Distribution Channel
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Indication
    • 11.3.4. By End-Use
    • 11.3.5. By Distribution Channel
  • 11.4. Key Takeaways

12. Europe Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Indication
    • 12.2.4. By End-Use
    • 12.2.5. By Distribution Channel
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Indication
    • 12.3.4. By End-Use
    • 12.3.5. By Distribution Channel
  • 12.4. Key Takeaways

13. South Asia Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. India
      • 13.2.1.2. Malaysia
      • 13.2.1.3. Singapore
      • 13.2.1.4. Thailand
      • 13.2.1.5. Rest of South Asia
    • 13.2.2. By Product
    • 13.2.3. By Indication
    • 13.2.4. By End-Use
    • 13.2.5. By Distribution Channel
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End-Use
    • 13.3.5. By Distribution Channel
  • 13.4. Key Takeaways

14. East Asia Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. China
      • 14.2.1.2. Japan
      • 14.2.1.3. South Korea
    • 14.2.2. By Product
    • 14.2.3. By Indication
    • 14.2.4. By End-Use
    • 14.2.5. By Distribution Channel
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End-Use
    • 14.3.5. By Distribution Channel
  • 14.4. Key Takeaways

15. Oceania Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 15.2.1. By Country
      • 15.2.1.1. Australia
      • 15.2.1.2. New Zealand
    • 15.2.2. By Product
    • 15.2.3. By Indication
    • 15.2.4. By End-Use
    • 15.2.5. By Distribution Channel
  • 15.3. Market Attractiveness Analysis
    • 15.3.1. By Country
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End-Use
    • 15.3.5. By Distribution Channel
  • 15.4. Key Takeaways

16. MEA Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 16.2.1. By Country
      • 16.2.1.1. GCC Countries
      • 16.2.1.2. South Africa
      • 16.2.1.3. Israel
      • 16.2.1.4. Rest of MEA
    • 16.2.2. By Product
    • 16.2.3. By Indication
    • 16.2.4. By End-Use
    • 16.2.5. By Distribution Channel
  • 16.3. Market Attractiveness Analysis
    • 16.3.1. By Country
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End-Use
    • 16.3.5. By Distribution Channel
  • 16.4. Key Takeaways

17. Key Countries Digital Respiratory Devices Market Analysis

  • 17.1. U.S.
    • 17.1.1. Pricing Analysis
    • 17.1.2. Market Share Analysis, 2023
      • 17.1.2.1. By Product
      • 17.1.2.2. By Indication
      • 17.1.2.3. By End-Use
      • 17.1.2.4. By Distribution Channel
  • 17.2. Canada
    • 17.2.1. Pricing Analysis
    • 17.2.2. Market Share Analysis, 2023
      • 17.2.2.1. By Product
      • 17.2.2.2. By Indication
      • 17.2.2.3. By End-Use
      • 17.2.2.4. By Distribution Channel
  • 17.3. Brazil
    • 17.3.1. Pricing Analysis
    • 17.3.2. Market Share Analysis, 2023
      • 17.3.2.1. By Product
      • 17.3.2.2. By Indication
      • 17.3.2.3. By End-Use
      • 17.3.2.4. By Distribution Channel
  • 17.4. Mexico
    • 17.4.1. Pricing Analysis
    • 17.4.2. Market Share Analysis, 2023
      • 17.4.2.1. By Product
      • 17.4.2.2. By Indication
      • 17.4.2.3. By End-Use
      • 17.4.2.4. By Distribution Channel
  • 17.5. Germany
    • 17.5.1. Pricing Analysis
    • 17.5.2. Market Share Analysis, 2023
      • 17.5.2.1. By Product
      • 17.5.2.2. By Indication
      • 17.5.2.3. By End-Use
      • 17.5.2.4. By Distribution Channel
  • 17.6. U.K.
    • 17.6.1. Pricing Analysis
    • 17.6.2. Market Share Analysis, 2023
      • 17.6.2.1. By Product
      • 17.6.2.2. By Indication
      • 17.6.2.3. By End-Use
      • 17.6.2.4. By Distribution Channel
  • 17.7. France
    • 17.7.1. Pricing Analysis
    • 17.7.2. Market Share Analysis, 2023
      • 17.7.2.1. By Product
      • 17.7.2.2. By Indication
      • 17.7.2.3. By End-Use
      • 17.7.2.4. By Distribution Channel
  • 17.8. Spain
    • 17.8.1. Pricing Analysis
    • 17.8.2. Market Share Analysis, 2023
      • 17.8.2.1. By Product
      • 17.8.2.2. By Indication
      • 17.8.2.3. By End-Use
      • 17.8.2.4. By Distribution Channel
  • 17.9. Italy
    • 17.9.1. Pricing Analysis
    • 17.9.2. Market Share Analysis, 2023
      • 17.9.2.1. By Product
      • 17.9.2.2. By Indication
      • 17.9.2.3. By End-Use
      • 17.9.2.4. By Distribution Channel
  • 17.10. India
    • 17.10.1. Pricing Analysis
    • 17.10.2. Market Share Analysis, 2023
      • 17.10.2.1. By Product
      • 17.10.2.2. By Indication
      • 17.10.2.3. By End-Use
      • 17.10.2.4. By Distribution Channel
  • 17.11. Malaysia
    • 17.11.1. Pricing Analysis
    • 17.11.2. Market Share Analysis, 2023
      • 17.11.2.1. By Product
      • 17.11.2.2. By Indication
      • 17.11.2.3. By End-Use
      • 17.11.2.4. By Distribution Channel
  • 17.12. Singapore
    • 17.12.1. Pricing Analysis
    • 17.12.2. Market Share Analysis, 2023
      • 17.12.2.1. By Product
      • 17.12.2.2. By Indication
      • 17.12.2.3. By End-Use
      • 17.12.2.4. By Distribution Channel
  • 17.13. Thailand
    • 17.13.1. Pricing Analysis
    • 17.13.2. Market Share Analysis, 2023
      • 17.13.2.1. By Product
      • 17.13.2.2. By Indication
      • 17.13.2.3. By End-Use
      • 17.13.2.4. By Distribution Channel
  • 17.14. China
    • 17.14.1. Pricing Analysis
    • 17.14.2. Market Share Analysis, 2023
      • 17.14.2.1. By Product
      • 17.14.2.2. By Indication
      • 17.14.2.3. By End-Use
      • 17.14.2.4. By Distribution Channel
  • 17.15. Japan
    • 17.15.1. Pricing Analysis
    • 17.15.2. Market Share Analysis, 2023
      • 17.15.2.1. By Product
      • 17.15.2.2. By Indication
      • 17.15.2.3. By End-Use
      • 17.15.2.4. By Distribution Channel
  • 17.16. South Korea
    • 17.16.1. Pricing Analysis
    • 17.16.2. Market Share Analysis, 2023
      • 17.16.2.1. By Product
      • 17.16.2.2. By Indication
      • 17.16.2.3. By End-Use
      • 17.16.2.4. By Distribution Channel
  • 17.17. Australia
    • 17.17.1. Pricing Analysis
    • 17.17.2. Market Share Analysis, 2023
      • 17.17.2.1. By Product
      • 17.17.2.2. By Indication
      • 17.17.2.3. By End-Use
      • 17.17.2.4. By Distribution Channel
  • 17.18. New Zealand
    • 17.18.1. Pricing Analysis
    • 17.18.2. Market Share Analysis, 2023
      • 17.18.2.1. By Product
      • 17.18.2.2. By Indication
      • 17.18.2.3. By End-Use
      • 17.18.2.4. By Distribution Channel
  • 17.19. GCC Countries
    • 17.19.1. Pricing Analysis
    • 17.19.2. Market Share Analysis, 2023
      • 17.19.2.1. By Product
      • 17.19.2.2. By Indication
      • 17.19.2.3. By End-Use
      • 17.19.2.4. By Distribution Channel
  • 17.20. South Africa
    • 17.20.1. Pricing Analysis
    • 17.20.2. Market Share Analysis, 2023
      • 17.20.2.1. By Product
      • 17.20.2.2. By Indication
      • 17.20.2.3. By End-Use
      • 17.20.2.4. By Distribution Channel
  • 17.21. Israel
    • 17.21.1. Pricing Analysis
    • 17.21.2. Market Share Analysis, 2023
      • 17.21.2.1. By Product
      • 17.21.2.2. By Indication
      • 17.21.2.3. By End-Use
      • 17.21.2.4. By Distribution Channel

18. Market Structure Analysis

  • 18.1. Competition Dashboard
  • 18.2. Competition Benchmarking
  • 18.3. Market Share Analysis of Top Players
    • 18.3.1. By Regional
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End-Use
    • 18.3.5. By Distribution Channel

19. Competition Analysis

  • 19.1. Competition Deep Dive
    • 19.1.1. COHERO Health Inc.
      • 19.1.1.1. Overview
      • 19.1.1.2. Product Portfolio
      • 19.1.1.3. Profitability by Market Segments
      • 19.1.1.4. Sales Footprint
      • 19.1.1.5. Strategy Overview
        • 19.1.1.5.1. Marketing Strategy
    • 19.1.2. Cognita Labs
      • 19.1.2.1. Overview
      • 19.1.2.2. Product Portfolio
      • 19.1.2.3. Profitability by Market Segments
      • 19.1.2.4. Sales Footprint
      • 19.1.2.5. Strategy Overview
        • 19.1.2.5.1. Marketing Strategy
    • 19.1.3. Adherium Limited
      • 19.1.3.1. Overview
      • 19.1.3.2. Product Portfolio
      • 19.1.3.3. Profitability by Market Segments
      • 19.1.3.4. Sales Footprint
      • 19.1.3.5. Strategy Overview
        • 19.1.3.5.1. Marketing Strategy
    • 19.1.4. Amiko Digital Health Limited
      • 19.1.4.1. Overview
      • 19.1.4.2. Product Portfolio
      • 19.1.4.3. Profitability by Market Segments
      • 19.1.4.4. Sales Footprint
      • 19.1.4.5. Strategy Overview
        • 19.1.4.5.1. Marketing Strategy
    • 19.1.5. Teva Pharmaceuticals Industries Ltd.
      • 19.1.5.1. Overview
      • 19.1.5.2. Product Portfolio
      • 19.1.5.3. Profitability by Market Segments
      • 19.1.5.4. Sales Footprint
      • 19.1.5.5. Strategy Overview
        • 19.1.5.5.1. Marketing Strategy
    • 19.1.6. Propeller Health
      • 19.1.6.1. Overview
      • 19.1.6.2. Product Portfolio
      • 19.1.6.3. Profitability by Market Segments
      • 19.1.6.4. Sales Footprint
      • 19.1.6.5. Strategy Overview
        • 19.1.6.5.1. Marketing Strategy
    • 19.1.7. Novartis AG
      • 19.1.7.1. Overview
      • 19.1.7.2. Product Portfolio
      • 19.1.7.3. Profitability by Market Segments
      • 19.1.7.4. Sales Footprint
      • 19.1.7.5. Strategy Overview
        • 19.1.7.5.1. Marketing Strategy
    • 19.1.8. Pneuma Respiratory Inc.
      • 19.1.8.1. Overview
      • 19.1.8.2. Product Portfolio
      • 19.1.8.3. Profitability by Market Segments
      • 19.1.8.4. Sales Footprint
      • 19.1.8.5. Strategy Overview
        • 19.1.8.5.1. Marketing Strategy
    • 19.1.9. 3M Health Care Limited
      • 19.1.9.1. Overview
      • 19.1.9.2. Product Portfolio
      • 19.1.9.3. Profitability by Market Segments
      • 19.1.9.4. Sales Footprint
      • 19.1.9.5. Strategy Overview
        • 19.1.9.5.1. Marketing Strategy
    • 19.1.10. AireHealth, Inc.
      • 19.1.10.1. Overview
      • 19.1.10.2. Product Portfolio
      • 19.1.10.3. Profitability by Market Segments
      • 19.1.10.4. Sales Footprint
      • 19.1.10.5. Strategy Overview
        • 19.1.10.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology